SeaStar Medical Holding Corporation
NASDAQ Capital MarketTotal Valuation
SeaStar Medical Holding Corporation carries a market capitalization of 555,125.00, placing it among publicly traded companies globally. Its enterprise value stands at -6.75M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 555,125.00 |
| Enterprise Value | -6.75M |
Share Statistics
SeaStar Medical Holding Corporation currently has 4.26M shares outstanding.
| Shares Outstanding | 4.26M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.02 |
| P/TBV Ratio | 0.02 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Financial Position
SeaStar Medical Holding Corporation maintains a current ratio of 1.89, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.12, indicating elevated leverage, while an interest coverage ratio of -518.11 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.89 |
| Quick Ratio | 1.65 |
| Debt / Equity | 3.12 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | -518.11 |
Financial Efficiency
| Return on Equity (ROE) | -356.87 |
| Return on Assets (ROA) | -160.02 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.64 |
Taxes
| Income Tax | 3,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
SeaStar Medical Holding Corporation's stock has declined approximately -61.49904% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.02.
| Beta (5Y) | N/A |
| 52-Week Price Change | -61.49904% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -13.99M, while operating income came in at -13.99M.
| Revenue | 1.71M |
| Gross Profit | 1.59M |
| Operating Income | -13.99M |
| Pretax Income | -13.62M |
| Net Income | -13.63M |
| EBITDA | -13.99M |
| EBIT | -13.99M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
SeaStar Medical Holding Corporation holds 6.96M in cash and equivalents against 134,000.00 in total debt, resulting in a net debt position of -6.82M. Total book value stands at 4.30M, with working capital of 3.88M providing operational flexibility.
| Cash & Cash Equivalents | 6.96M |
| Total Debt | 134,000.00 |
| Net Debt | -6.82M |
| Equity (Book Value) | 4.30M |
| Book Value Per Share | 1.01 |
| Working Capital | 3.88M |
Cash Flow
SeaStar Medical Holding Corporation produced -13.69M in operating cash flow over the past twelve months.
| Operating Cash Flow | -13.69M |
| Capital Expenditures | N/A |
| Free Cash Flow | -13.69M |
| FCF Per Share | N/A |
Margins
SeaStar Medical Holding Corporation operates with a gross margin of 92.64, reflecting its pricing power and cost economics. The operating margin of -816.64 and net profit margin of -795.50 provide insight into operational efficiency.
| Gross Margin | 92.64 |
| Operating Margin | -816.64 |
| Pretax Margin | -795.33 |
| Profit Margin | -795.50 |
| EBITDA Margin | -816.64 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -19,472.08 |
| FCF Yield | N/A |
Scores
SeaStar Medical Holding Corporation posts an Altman Z-Score of -30.32, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -30.32 |